CordenPharma Latina Approved for Clinical Supply of Sterile Oncology Lyophilised Products

Jul 13, 2015
CordenPharma is pleased to announce that the Sterile Oncology Suite in its CordenPharma Latina (IT) manufacturing facility has received approval for Clinical Supply of Sterile Oncology Lyophilised Products. This newly expanded capability perfectly complements the CordenPharma Highly Potent and Oncology Technology Platforms, in addition to the already available Development and Clinical Capability for Solid Dosage in CordenPharma Plankstadt (DE) and APIs in CordenPharma Colorado (USA).

With this approval CordenPharma continues to expand its service offering in the containment field spanning from development to well-established worldwide commercial supply, serving its customers as The Expert Source for Highly Potent & Oncological Products.